Close

NovaBay Pharma (NBY) Tops Q4 EPS by 2c, Beats on Revenues

March 20, 2018 4:07 PM EDT

Note: EPS may not be comparable

NovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $6.32 million versus the consensus estimate of $5.97 million.

For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings